Litcius/Paper detail

Long-term in vivo imaging reveals tumor-specific dissemination and captures host tumor interaction in zebrafish xenografts

Nandini Asokan, Stephan Daetwyler, Stefanie N. Bernas, Christopher Schmied, Steffen Vogler, Katrin Lambert, Manja Wobus, Martin Wermke, Gerd Kempermann, Jan Huisken, Michael Brand, Martin Bornhäuser

2020Scientific Reports36 citationsDOIOpen Access PDF

Abstract

Understanding mechanisms mediating tumor metastasis is crucial for diagnostic and therapeutic targeting. Here, we take advantage of a transparent embryonic zebrafish xenograft model (eZXM) to visualize and track metastatic cells in real time using selective plane illumination microscopy (SPIM) for up to 30 h. Injected human leukemic and breast cancer cells exhibited cell-type specific patterns of intravascular distribution with leukemic cells moving faster than breast cancer cells. Tracking of tumor cells from high-resolution images revealed acute differences in intravascular speed and distance covered by cells. While the majority of injected breast cancer cells predominantly adhered to nearby vasculature, about 30% invaded the non-vascularized tissue, reminiscent of their metastatic phenotype. Survival of the injected tumor cells appeared to be partially inhibited and time-lapse imaging showed a possible role for host macrophages of the recipient embryos. Leukemic cell dissemination could be effectively blocked by pharmacological ROCK1 inhibition using Fasudil. These observations, and the ability to image several embryos simultaneously, support the use of eZXM and SPIM imaging as a functional screening platform to identify compounds that suppress cancer cell spread and invasion.

Topics & Concepts

ZebrafishCancer cellMetastasisCancer researchCancerPathologyIn vivoBreast cancerLive cell imagingCellMetastatic breast cancerEmbryonic stem cellBiologyMedicineInternal medicineGeneGeneticsBiotechnologyBiochemistryZebrafish Biomedical Research ApplicationsAdvanced Fluorescence Microscopy TechniquesAngiogenesis and VEGF in Cancer